250 related articles for article (PubMed ID: 33866126)
21. Safety and efficacy of perampanel in children and adults with various epilepsy syndromes: A single-center postmarketing study.
Singh K; Shah YD; Luciano D; Friedman D; Devinsky O; Kothare SV
Epilepsy Behav; 2016 Aug; 61():41-45. PubMed ID: 27300147
[TBL] [Abstract][Full Text] [Related]
22. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes.
DeLorenzo RJ; Garnett LK; Towne AR; Waterhouse EJ; Boggs JG; Morton L; Choudhry MA; Barnes T; Ko D
Epilepsia; 1999 Feb; 40(2):164-9. PubMed ID: 9952262
[TBL] [Abstract][Full Text] [Related]
23. The neuroprotective effect of perampanel in lithium-pilocarpine rat seizure model.
Wu T; Ido K; Osada Y; Kotani S; Tamaoka A; Hanada T
Epilepsy Res; 2017 Nov; 137():152-158. PubMed ID: 28624183
[TBL] [Abstract][Full Text] [Related]
24. Etiology, clinical course and response to the treatment of status epilepticus in children: A 16-year single-center experience based on 602 episodes of status epilepticus.
Kravljanac R; Djuric M; Jankovic B; Pekmezovic T
Eur J Paediatr Neurol; 2015 Sep; 19(5):584-90. PubMed ID: 26143956
[TBL] [Abstract][Full Text] [Related]
25. Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
Strzelczyk A; Willems LM; Willig S; Rosenow F; Bauer S
Expert Rev Clin Pharmacol; 2015; 8(6):733-40. PubMed ID: 26436331
[TBL] [Abstract][Full Text] [Related]
26. Indications for the use of intravenous second-line antiseizure medications in an emergency room setting.
Pöytäkangas T; Saarinen JT; Basnyat P; Rainesalo S; Peltola J
Epilepsy Res; 2023 Oct; 196():107218. PubMed ID: 37647825
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of perampanel in refractory nonconvulsive status epilepticus and simple partial status epilepticus.
Redecker J; Wittstock M; Benecke R; Rösche J
Epilepsy Behav; 2015 Apr; 45():176-9. PubMed ID: 25819947
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies.
Steinhoff BJ; Patten A; Williams B; Malhotra M
Epilepsia; 2020 Feb; 61(2):278-286. PubMed ID: 31944276
[TBL] [Abstract][Full Text] [Related]
29. Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model.
Leclercq K; Kaminski RM
Epilepsy Behav; 2015 Aug; 49():55-60. PubMed ID: 26123104
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies-An Italian observational multicenter study.
De Liso P; Vigevano F; Specchio N; De Palma L; Bonanni P; Osanni E; Coppola G; Parisi P; Grosso S; Verrotti A; Spalice A; Nicita F; Zamponi N; Siliquini S; Giordano L; Martelli P; Guerrini R; Rosati A; Ilvento L; Belcastro V; Striano P; Vari MS; Capovilla G; Beccaria F; Bruni O; Luchetti A; Gobbi G; Russo A; Pruna D; Tozzi AE; Cusmai R
Epilepsy Res; 2016 Nov; 127():93-100. PubMed ID: 27568598
[TBL] [Abstract][Full Text] [Related]
32. Early versus late switch over of antiseizure medications from intravenous to the oral route in children with seizures: Single-blinded, randomized controlled trial (ELAIO trial).
Panda PK; Bhardwaj S; Murugan VK; Elwadhi A; Dhamija P; Tiwari L; Sharawat IK
Epilepsy Res; 2024 May; 202():107360. PubMed ID: 38652997
[TBL] [Abstract][Full Text] [Related]
33. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
Gidal BE; Ferry J; Majid O; Hussein Z
Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
[TBL] [Abstract][Full Text] [Related]
34. Sublingual lorazepam as rescue therapy for seizure emergencies in adults.
Lelis IR; Krauss GL
Epilepsy Behav; 2023 Aug; 145():109294. PubMed ID: 37406555
[TBL] [Abstract][Full Text] [Related]
35. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment.
Mitchell WG
Epilepsia; 1996; 37 Suppl 1():S74-80. PubMed ID: 8647055
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures.
Piña-Garza JE; Lagae L; Villanueva V; Renfroe JB; Laurenza A; Williams B; Kumar D; Meador KJ
Epilepsy Behav; 2018 Jun; 83():50-58. PubMed ID: 29653338
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies.
Piña-Garza JE; Rosenfeld W; Saeki K; Villanueva V; Yoshinaga H; Patten A; Williams B; Malhotra M
Epilepsy Behav; 2020 Mar; 104(Pt A):106876. PubMed ID: 31954998
[TBL] [Abstract][Full Text] [Related]
38. Reponse of second-line treatment in focal status epilepticus: A tertiary hospital experience.
Llauradó A; Campos D; Quintana M; Ballvé A; Fonseca E; Abraira L; Giffreu A; Toledo M; Santamarina E
Epilepsy Res; 2022 Sep; 185():106988. PubMed ID: 35907324
[TBL] [Abstract][Full Text] [Related]
39. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures.
Gil-López FJ; Montoya J; Falip M; Aparicio J; López-González FJ; Toledano R; Gil-Nagel A; Molins A; García I; Serrano P; Domenech G; Torres F; Donaire A; Carreño M
Acta Neurol Scand; 2018 Aug; 138(2):122-129. PubMed ID: 29573400
[TBL] [Abstract][Full Text] [Related]
40. Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study.
Poddar K; Sharma R; Ng YT
Pediatr Neurol; 2016 Aug; 61():83-6. PubMed ID: 27241232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
